Treatment of Patients with Non-Hodgkin Lymphoma (NHL) with CD19/CD3 Bispecific Antibody Blinatumomab (MT103): Double-Step Dose Increase to Continuous Infusion of 60 μg/m2/d Is Tolerable and Highly Effective
| Autor: | Viardot, Andreas *, Goebeler, Mariele *, Scheele, Jurgen S. *, Zugmaier, Gerhard, Noppeney, Richard *, Knop, Stefan *, Topp, Max S *, Nagorsen, Dirk *, Klinger, Matthias *, Schmidt, Margit *, Klappers, Petra *, Kufer, Peter *, Einsele, Hermann, Bargou, Ralf * |
|---|---|
| Zdroj: | In Blood 19 November 2010 116(21):2880-2880 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|